March 7 (Reuters) - U.S. medical devices maker Biomet Inc filed with U.S. regulators on Friday to raise up to $100 million in an initial public offering of its common shares as its private equity owners look to cash out.
The company, which was taken private for $11.4 billion in 2007, said BofA Merrill Lynch, Goldman Sachs and J.P. Morgan were the lead underwriters to the offering. ()
The private equity arm of Goldman Sachs Group Inc, Blackstone Group LP, KKR & Co LP and TPG Capital LP own 97.04 percent of Biomet.
Founded in 1977 and based in Warsaw, Indiana, Biomet designs, manufactures and markets products that include dental implants and artificial hip joints.
Biomet competes with Smith & Nephew Plc and Stryker Corp .
Biomet was bought out just before the financial crisis hit, pulling the markets down. The crisis hurt the medical device industry as patients delayed surgery and joint replacements.
The company will list its shares under the symbol "BMET". It did not say how many shares it will offer or the exchange it will list on.
The amount of money a company says it plans to raise in its first IPO filing is used to calculate registration fees. The final size of the IPO could be different.